Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Life Science Reit Plc ( (GB:LABS) ) just unveiled an update.
Life Science REIT plc has announced a strategic review to explore options for maximizing shareholder value, prompted by challenges such as high inflation, elevated interest rates, and low liquidity, which have led to a prolonged discount in share price. Despite these challenges, the company has made progress in leasing activities and cost-saving measures, with a focus on capturing rental growth and completing development projects, while future dividends are suspended pending the review’s outcome.
More about Life Science Reit Plc
Life Science REIT plc is a specialist property business focused on the UK’s growing life science sector. The company operates a portfolio of assets located in the ‘Golden Triangle’ of research and development hubs in Oxford, Cambridge, and London’s Knowledge Quarter. Life Science REIT is listed on the Main Market of the London Stock Exchange under the ticker LABS.
YTD Price Performance: 16.84%
Average Trading Volume: 895,450
Technical Sentiment Signal: Sell
Current Market Cap: £152.6M
See more data about LABS stock on TipRanks’ Stock Analysis page.